The direct answer

Bodycote (LSE:BOY) attracted rival private-equity suitors because it is a global leader in an unglamorous but essential industrial service, thermal processing, that throws off steady cash and looked cheaply valued on the London market. That interest has now resolved: on 1 September 2026 Bodycote's board unanimously recommended a 940p-per-share cash offer from Veritas Capital, valuing the FTSE 250 group's Equity at roughly £1.6bn, after a competitive tussle with CVC.

So the situation has moved beyond competing bidders to an agreed, recommended deal. Veritas prevailed with a 940p offer, comprising 932.8p in cash plus a 7.2p interim dividend, topping CVC's 915p. Importantly, the Acquisition is agreed but not yet completed; it still requires Shareholder and regulatory approval, with completion expected around the first quarter of 2027. For now the shares trade close to the offer price, reflecting expectations that the deal will complete on agreed terms.

What Bodycote does

Bodycote is the world's largest provider of heat treatment and specialist thermal processing services. In simple terms, it strengthens and hardens metal parts for other manufacturers, treating components used in aircraft engines, cars, energy equipment and industrial machinery. Because building the furnaces and expertise in-house is costly, manufacturers outsource this work, giving Bodycote a defensive, mission-critical niche.

That combination, an essential service, high barriers to entry and dependable cash generation, is exactly what makes the Business attractive to private equity, which favours stable, cash-producing companies it can own away from public markets. Bodycote generates cash steadily through the cycle and pays reliable dividends, and its exposure to aerospace and energy offers recovery potential that a private owner could pursue without quarterly scrutiny.

Why the bids emerged

Two forces drew in bidders. First, Bodycote's shares had drifted, leaving its valuation looking modest relative to the quality and market position of the business. Second, private-equity firms are sitting on large pools of Capital and have been targeting undervalued, cash-generative UK industrials, where a weaker pound and low ratings have made London-listed companies relatively cheap to acquire, with sterling weakness making UK Assets look like bargains to dollar-based buyers.

The 940p offer represents about a 37.5% premium to Bodycote's average share price in the three months before Takeover speculation emerged, the kind of uplift that made it hard for the board to argue shareholders would do better by staying independent. The rival approach from CVC helped push the final price higher, illustrating how a contested auction can benefit selling shareholders. The premium also reflects Bodycote's entrenched position: replicating its global network of processing plants would take years and heavy capital, a moat that appeals to buyers seeking dependable, inflation-resilient cash flows.

Risks and what to watch

Even a recommended, all-cash deal is not certain to complete. It remains conditional on approval by Bodycote shareholders and on competition and regulatory clearances in the jurisdictions where Bodycote operates, any of which could impose conditions or cause delay. Bodycote operates plants across Europe, North America and Asia, so several competition authorities may need to sign off, which could extend the timetable. Should the deal fall through, the shares, which have risen towards the offer price, could give back much of that gain.

For existing holders, an agreed cash takeover crystallises value now but ends any exposure to Bodycote's longer-term recovery and to the wider industrial upcycle. Some may feel 940p undervalues a global leader, though the board's unanimous recommendation signals it judged the terms fair. Investors should note that timelines and conditions are set out in the formal scheme documentation rather than guaranteed. The key things to watch are the shareholder vote, the progress of regulatory clearances, whether any counter-bidder re-emerges, and the confirmed completion date, currently anticipated in early 2027.